These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 31431043)

  • 1. Biomarkers for Stratification in Colorectal Cancer: MicroRNAs.
    Fadaka AO; Pretorius A; Klein A
    Cancer Control; 2019; 26(1):1073274819862784. PubMed ID: 31431043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis.
    Chen B; Xia Z; Deng YN; Yang Y; Zhang P; Zhu H; Xu N; Liang S
    Open Biol; 2019 Jan; 9(1):180212. PubMed ID: 30958116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Role of MicroRNAs in Colorectal Cancer].
    Kim SW
    Korean J Gastroenterol; 2017 Apr; 69(4):206-211. PubMed ID: 28449421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Dual Role of MicroRNAs in Colorectal Cancer Progression.
    Ding L; Lan Z; Xiong X; Ao H; Feng Y; Gu H; Yu M; Cui Q
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of miRNAs in colorectal cancer progression and chemoradiotherapy.
    Zhang N; Hu X; Du Y; Du J
    Biomed Pharmacother; 2021 Feb; 134():111099. PubMed ID: 33338745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.
    Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM
    Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting miRNA signature in colorectal cancer progression and metastasis.
    Huang X; Zhu X; Yu Y; Zhu W; Jin L; Zhang X; Li S; Zou P; Xie C; Cui R
    Cancer Lett; 2021 Mar; 501():66-82. PubMed ID: 33385486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as potential investigative and predictive biomarkers in colorectal cancer.
    Yaghoubi N; Zahedi Avval F; Khazaei M; Aghaee-Bakhtiari SH
    Cell Signal; 2021 Apr; 80():109910. PubMed ID: 33387618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of microRNA deregulation in colorectal cancer development and the clinical uses as a diagnostic and prognostic biomarker and therapeutic agent.
    Ahadi A
    Noncoding RNA Res; 2020 Sep; 5(3):125-134. PubMed ID: 32954092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of non-coding RNAs as novel biomarkers for detection of colorectal cancer progression through interaction with the cell signaling pathways.
    Esmaeili M; Keshani M; Vakilian M; Esmaeili M; Peymani M; Seyed Forootan F; Chau TL; Göktuna SI; Zaker SR; Nasr Esfahani MH; Ghaedi K
    Gene; 2020 Aug; 753():144796. PubMed ID: 32450203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentials of long non-coding RNAs as biomarkers of colorectal cancer.
    Lv Y; Wang Y; Zhang Z; Bao J; Su H
    Clin Transl Oncol; 2022 Sep; 24(9):1715-1731. PubMed ID: 35581419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on microRNAs as colorectal cancer biomarkers: where are we and what's next?
    Okugawa Y; Toiyama Y; Goel A
    Expert Rev Mol Diagn; 2014 Nov; 14(8):999-1021. PubMed ID: 25163355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-coding RNAs as Biomarkers for Survival in Colorectal Cancer Patients.
    Andrabi MQ; Kesavan Y; Ramalingam S
    Curr Aging Sci; 2024; 17(1):5-15. PubMed ID: 36733201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated microRNAs in colorectal carcinogenesis: New insight to cell survival and apoptosis regulation.
    Anvarnia A; Mohaddes-Gharamaleki F; Asadi M; Akbari M; Yousefi B; Shanehbandi D
    J Cell Physiol; 2019 Dec; 234(12):21683-21693. PubMed ID: 31131450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer.
    Moridikia A; Mirzaei H; Sahebkar A; Salimian J
    J Cell Physiol; 2018 Feb; 233(2):901-913. PubMed ID: 28092102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
    Zou G; Wang R; Wang M
    Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulated microRNAs in the colorectal cancer: diagnostic and therapeutic perspectives.
    Hernández R; Sánchez-Jiménez E; Melguizo C; Prados J; Rama AR
    BMB Rep; 2018 Nov; 51(11):563-571. PubMed ID: 30158023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
    Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
    Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs and colorectal cancer: clinical potential and regulatory networks.
    Osei GY; Adu-Amankwaah J; Koomson S; Beletaa S; Asiamah EA; Smith-Togobo C; Razak SRA
    Mol Biol Rep; 2023 Nov; 50(11):9575-9585. PubMed ID: 37776413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.